Az albuminuria vizsgálata a csökkent ejekciós frakciójú szívelégtelenség első vonalbeli gyógyszeres terápiájának tükrében

20260 citationsJournal Article

Authors

Zsolt Forrai · University of Szeged

Pál Péter Schäffer · Gottsegen National Cardiovascular Center

Tamás G. Gergely · Gottsegen National Cardiovascular Center

Ádám Kazay · Gottsegen National Cardiovascular Center

Laura Fanni Hanuska · Gottsegen National Cardiovascular Center

Kata Czurkó · Gottsegen National Cardiovascular Center

Dávid Pilecky

Abstract

Our results highlight the importance of UACR in the identification of high-risk HFrEF patients. Guideline-directed medical therapy implementation was possible among them as well, underscoring the need of continuous therapy-optimization in wide spectrum of albuminuria. Orv Hetil. 2026; 167(10): 383-395.

Topics & Keywords

Chronic Kidney Disease and Diabetes Cardiovascular Health and Disease Prevention Bariatric Surgery and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Orvosi Hetilap

Volume 167, Issue 10, pp. 383-395

DOI: 10.1556/650.2026.33492

Field-Weighted Citation Impact: 0.00